Prescription drug · NDA
Wynzora NDC 73499-001
calcipotriene and betamethasone dipropionate · Calcipotriene 50 ug/g; Betamethasone dipropionate 64 mg/g · Cream · Topical · MC2 Therapeutics Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73499-001-01 | 73499000101 | 1 TUBE in 1 CARTON (73499-001-01) / 60 g in 1 TUBEMarketed from Jun 30, 2021 | |
| 73499-001-03 | 73499000103 | 10 TUBE in 1 CARTON (73499-001-03) / 5 g in 1 TUBEMarketed from Jun 30, 2021 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Wynzora
- Generic name (nonproprietary)
- calcipotriene and betamethasone dipropionate
- Active ingredients
- Calcipotriene — 50 ug/gBetamethasone dipropionate — 64 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- MC2 Therapeutics Ltd
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 213422
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)Vitamin D (Chemical structure)
- Identifiers
- Product ID 73499-001_22617d3b-9736-472b-bc08-1ce53fe151aaSPL ID 22617d3b-9736-472b-bc08-1ce53fe151aaSPL set ID 36c5c818-0d40-445e-a3c0-0f46723a25e2RxCUI 2471873, 2471878UNII 143NQ3779B, 826Y60901U
- Pharmacologic class
- Corticosteroid; Vitamin D Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473499000101followed by a unit qualifier and the quantityPackage 73499-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
WYNZORA Cream is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older. WYNZORA Cream is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.